Evidence map›Paper›PMID 32284020›Full record

ArticleThyroid : official journal of the American Thyroid Association2020

Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.

Bin Xu, Talia Fuchs, Snjezana Dogan, Iñigo Landa, Nora Katabi, James A Fagin, R Michael Tuttle, Eric Sherman, Anthony J Gill, Ronald Ghossein

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06878534 (Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy), which is not on this map. Cited by 155 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 4 pooled it
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06878534 recruitingnot on this mapstarted 2023, after this paper: background citation

Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy

TypeobservationalSponsorIRCCS SYNLAB SDNRan2023 to 2027Enrolled80ConditionsThyroid Cancer
3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 4 syntheses or guidelines pooled it, 282 citations in OpenAlex.

  1. The efficacy of various treatment modalities and their combinations in improving survival outcomes for anaplastic thyroid cancer: a systematic review and network meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2021
    Guideline
  5. Trial
  6. Prognostic value of volume-based metabolic parameters of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Article
  8. SMARCA4-deficient Anaplastic Thyroid Carcinoma: A Hitherto Unreported Case.Virchows Archiv : an international journal of pathology · 2026
    Article
  9. Genomics and Multi-Omics to Guide Clinical Management in Thyroid Cancer.International journal of molecular sciences · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Bin XuDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Talia FuchsSydney NSW Australia and Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, Sydney, Australia.
Snjezana DoganDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Iñigo LandaHuman Oncology and Pathogenesis Program, and Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Nora KatabiDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
James A FaginHuman Oncology and Pathogenesis Program, and Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
R Michael TuttleDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Eric ShermanDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Anthony J GillSydney NSW Australia and Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, Sydney, Australia.
Ronald GhosseinDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Memorial Sloan Kettering Cancer Center · USRoyal North Shore Hospital · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
SPORE in Thyroid CancerP50CA172012 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI FAGIN, JAMES A · 2014 to 2018
$10.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA172012
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overFemaleGenotypeGTP PhosphohydrolasesHumansImmunophenotypingMaleMembrane ProteinsMiddle AgedMitosisMutationNecrosisNeoplasm MetastasisPhenotypeBRAF protein, humanGTP PhosphohydrolasesMembrane ProteinsNRAS protein, humanProto-Oncogene Proteins B-rafTelomeraseTERT protein, humananaplastic thyroid carcinomaBRAFprognosisRASTERTundifferentiated thyroid carcinoma

Identifiers

PMID32284020
PMCPMC7583343
OpenAlexW3016136761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.